BridgeBio Oncology Therapeutics, Inc. BBOT
- BBO-10203 — Breast Cancer Phase 1
- BBO-10203 — Colorectal Cancer Phase 1
- BBO-10203 — Non-Small Cell Lung Cancer Phase 1
- BBO-10203 — Pancreatic Ductal Adenocarcinoma Phase 1
Home › Targets › PI3Kα RAS-binding domain
PI3Kα RAS-binding domain (1 companies · 4 programs)
Companies with an active program directed at PI3Kα RAS-binding domain.